These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1385941)

  • 1. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold.
    Wilkinson SM; Smith AG; Davis MJ; Mattey D; Dawes PT
    Ann Rheum Dis; 1992 Jul; 51(7):881-4. PubMed ID: 1385941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scarring alopecia following gold therapy.
    Burrows NP; Grant JW; Crisp AJ; Roberts SO
    Acta Derm Venereol; 1994 Nov; 74(6):486. PubMed ID: 7701895
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cutaneous side effects of gold therapy. Clinical and histologic results].
    Hofmann C; Burg G; Jung C
    Z Rheumatol; 1986; 45(3):100-6. PubMed ID: 2944308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 5. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study.
    Harth M; Davis P; Thompson JM; Menard H; Beaudet F
    Scand J Rheumatol; 1987; 16(3):177-84. PubMed ID: 3110944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.
    Svensson A; Theander J
    Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auranofin in rheumatoid arthritis: use in patients with side-effects or lack of effect to gold sodium thiomalate or gold thioglucose and/or D-penicillamine. A prospective one year investigation.
    Manthorpe R; Tvede N; Bendixen G
    Scand J Rheumatol; 1988; 17(5):401-5. PubMed ID: 3145556
    [No Abstract]   [Full Text] [Related]  

  • 9. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
    Davis P; Landon M
    J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724
    [No Abstract]   [Full Text] [Related]  

  • 12. A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA).
    Rau R; Schattenkirchner M; Müller-Fassbender H; Kaik B; Zeidler H
    Clin Rheumatol; 1987 Sep; 6 Suppl 2():43-52. PubMed ID: 3121238
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gold-induced severe cholestatic jaundice in rheumatoid arthritis patient and effect of repeated steroid pulse therapy].
    Yamanishi Y; Takeda M; Honjo N; Aoi K; Ishibe Y; Yamana S
    Ryumachi; 1992 Oct; 32(5):475-82; discussion 480-1. PubMed ID: 1440084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin-induced vasomotor reaction.
    Proudman SM; Cleland LG
    Arthritis Rheum; 1992 Dec; 35(12):1452-4. PubMed ID: 1472122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold dermatitis. A clinical and histopathological study.
    Penneys NS; Ackerman AB; Gottlieb NL
    Arch Dermatol; 1974 Mar; 109(3):372-6. PubMed ID: 4273615
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gold salt alveolitis in 3 patients with rheumatoid arthritis].
    Music E; Tomsic M; Logar D
    Pneumologie; 1995 Jun; 49(6):367-72. PubMed ID: 7644457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
    Klinefelter
    J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
    Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
    Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.